Neuland Laboratories Stock Forecast for 2023 - 2025 - 2030

Updated on 05/06/2024

Stock Rating
18
Price Target
Rp8.30k
Consensus
Outperform
Upside
10.07%
Analysts
1
Stock Rating
18
Upside
10.07%
Analysts
1
Price Target
Rp8.30k

Neuland Laboratories Stock Forecast and Price Target

Neuland Laboratories has an average price target of Rp8300.00 recently offered by notable experts for 2024, which would represent a potential upside of approximately 10.07% from the last closing price in May, 2024 if reached. This potential increase is based on a high estimate of Rp9100.00 and a low estimate of Rp7500.00. If you're looking for information on Neuland Laboratories stock, consider checking out the forecasts for comparable firms such as BSE:524348.

Rp8.30k

10.07% Upside

Buy
Buy

Neuland Laboratories Fair Value Forecast for 2023 - 2025 - 2030

In the last five years, Neuland Laboratories's Price has seen a drop from Rp403.91 to Rp0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach Rp7492.91 – an increase of 100.00%. For the next six years, experts predict that Neuland Laboratories's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
Rp7.49k
2026 Fair Value Forecast
Rp9.60k
2027 Fair Value Forecast
Rp8.90k
2028 Fair Value Forecast
Rp5.51k
2029 Fair Value Forecast
Rp6.38k
2030 Fair Value Forecast
Rp7.57k
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DIVISLAB Stock Forecast Divi's Laboratories Hold 18
Rp3.95k Buy/Sell Rp3.30k -14.83%
JUBLFOOD Stock Forecast Jubilant FoodWorks Hold 18
Rp462.75 Buy/Sell Rp524.21 8.05%
LAURUSLABS Stock Forecast Laurus Labs Hold 18
Rp447.35 Buy/Sell Rp370.83 -16.17%
SUVENPHAR Stock Forecast Suven Pharmaceuticals Hold 18
Rp672.10 Buy/Sell Rp605.00 1.99%
532482 Stock Forecast Granules India Buy 18
Rp423.35 Buy/Sell Rp381.00 13.38%

Neuland Laboratories Revenue Forecast for 2023 - 2025 - 2030

Neuland Laboratories's Revenue has grown In the last three years, rising from Rp7.64B to Rp11.91B – a growth of 55.95%. In the next year, analysts believe that Revenue will reach Rp17.35B – an increase of 45.64%. For the next six years, experts predict that Neuland Laboratories's Revenue will grow at a rate of 20.39%.

2025 Rev Forecast
Rp17.35B
2026 Rev Forecast
Rp14.29B
2027 Rev Forecast
Rp12.86B
2028 Rev Forecast
Rp12.91B
2029 Rev Forecast
Rp14.30B
2030 Rev Forecast
Rp14.34B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
530549 Stock Forecast Shilpa Medicare - 16
Rp535.40 Buy/Sell Rp346.00 -100.00%
524348 Stock Forecast Aarti Drugs Outperform 16
Rp501.35 Buy/Sell Rp612.50 12.10%
524735 Stock Forecast Hikal Buy 18
Rp297.45 Buy/Sell Rp328.00 10.94%

Neuland Laboratories Dividend per Share Forecast for 2023 - 2025 - 2030

Neuland Laboratories's Dividend per Share has seen impressive growth In the last three years, rising from Rp2.00 to Rp10.00 – a growth of 400.00%. In the next year, 1 analysts estimate that Neuland Laboratories's Dividend per Share will decrease by 1.10%, reaching Rp9.89. For the next six years, the forecast is for Dividend per Share to grow by 21.61%.

2025 DPS Forecast
Rp9.89
2026 DPS Forecast
Rp14.51
2027 DPS Forecast
Rp10.61
2028 DPS Forecast
Rp10.82
2029 DPS Forecast
Rp10.93
2030 DPS Forecast
Rp12.16
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SOLARA Stock Forecast Solara Active Pharma Sciences Outperform 9
Rp553.60 Buy/Sell Rp395.00 -36.78%
530239 Stock Forecast Suven Life Sciences 9
Rp106.00 Buy/Sell Rp306.00 470.75%
524212 Stock Forecast Wanbury - -8
Rp148.95 Buy/Sell Rp0.00 -100.00%

Neuland Laboratories Free Cash Flow Forecast for 2023 - 2025 - 2030

2025 FCF Forecast
Rp2.36B
2026 FCF Forecast
Rp3.23B
2027 FCF Forecast
Rp2.36B
2028 FCF Forecast
Rp2.72B
2029 FCF Forecast
Rp2.69B
2030 FCF Forecast
Rp2.91B

Neuland Laboratories EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Neuland Laboratories's EBITDA has grown, moving from Rp1.02B to Rp2.79B – an increase of 173.08%. In the next year, analysts predict that EBITDA will jump to Rp4.73B – up 69.57% from the current level. Looking ahead to six years, experts forecast that EBITDA will grow by 74.04%.

2025 EBITDA Forecast
Rp4.73B
2026 EBITDA Forecast
Rp5.93B
2027 EBITDA Forecast
Rp3.74B
2028 EBITDA Forecast
Rp3.70B
2029 EBITDA Forecast
Rp4.19B
2030 EBITDA Forecast
Rp4.86B

Neuland Laboratories EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Neuland Laboratories's EBIT has seen an increase, rising from Rp735.99M to Rp2.31B. This represents a growth of 213.26%. Analysts predict that Neuland Laboratories's EBIT will increase in the upcoming year, reaching Rp4.40B. This would represent an increase of 91.02%. Over the next six years, experts predict that Neuland Laboratories's EBIT will grow at a rate of 97.33%.

2025 EBIT Forecast
Rp4.40B
2026 EBIT Forecast
Rp5.58B
2027 EBIT Forecast
Rp3.22B
2028 EBIT Forecast
Rp3.27B
2029 EBIT Forecast
Rp3.82B
2030 EBIT Forecast
Rp4.55B

Neuland Laboratories EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last five years, Neuland Laboratories's EPS has seen a drop from Rp12.63 to Rp0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach Rp234.30 – an increase of 100.00%. For the next six years, experts predict that Neuland Laboratories's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
Rp234.30
2026 EPS Forecast
Rp300.20
2027 EPS Forecast
Rp278.24
2028 EPS Forecast
Rp172.45
2029 EPS Forecast
Rp199.63
2030 EPS Forecast
Rp236.64